- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Melanoma survivors at increased risk for second primary BCC and SCC: Study
China: Findings from a recent study published in the International Journal of Dermatology, have suggested that melanoma survivors are at increased risk for second primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). This indicates the significance of monitoring for second primary keratinocyte carcinoma and efforts for prevention in patients with melanoma history.
Recent large cohorts have demonstrated that melanoma survivors are at risk for the development of second KC. However, nothing is known about detailed proportion and risk. Guangtong Deng, Department of Oncology, Xiangya Hospital, Central South University, Changsha, China, and colleagues aimed to comprehensively analyze the risk of developing keratinocyte carcinoma after primary melanoma.
For this purpose, the researcher conducted systematic literature research in online databases published prior to September 13, 2021. The risk was assessed using proportion and standardized incidence ratios (SIR). The analysis included a total of 15 studies encompassing 168,286 patients.
The study revealed the following findings:
- The pooled proportions of melanoma survivors that developed a subsequent basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and KC were 4.11%, 2.54%, and 5.45% respectively.
- The risks of developing a second BCC, SCC, and KC in melanoma survivors were 5.3-fold (SIR 5.30), 2.6-fold (SIR 2.58), and 6.2-fold (SIR 6.17) increased in comparison with the general population.
- Both fixed effects and random effects models were applied in conducting meta-analysis and reached a consistent conclusion.
"Our findings indicated melanoma survivors are at elevated risk of experiencing second primary BCC and SCC," the authors wrote in their study.
"In melanoma survivors, routine full-body skin examinations and continued vigilant surveillance for not only recurrent and subsequent primary melanoma but also non-melanoma skin cancers are important due to the increased risk of these conditions."
Reference:
Sun H, Li Y, Zeng F, Meng Y, Du S, Deng G. Melanoma survivors are at increased risk for second primary keratinocyte carcinoma. Int J Dermatol. 2022 Jun 21. doi: 10.1111/ijd.16309. Epub ahead of print. PMID: 35726477.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751